Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein-associated protein N (SNRPN) is a human protein encoded by the SNRPN gene and forms part of the small nuclear ribonucleoprotein (snRNP) complexes, specifically the Sm-class of snRNPs[1][5]. These complexes play a critical role in nuclear RNA processing, including pre-mRNA splicing and potentially tissue-specific alternative splicing events, acting within the spliceosome to remove introns from precursor mRNA[1][2][6]. SNRPN is involved in imprinting and gene regulation, particularly within the Prader-Willi syndrome critical region on chromosome 15; defects in this gene, such as abnormal imprinting, are linked to Prader-Willi syndrome[1][5]. SNRPN is not a conventional receptor, enzyme, or drug target, and there are no known drugs that directly interact with it or target it for therapeutic intervention. SNRPN methylation status is used clinically as a biomarker for diagnosing uniparental disomy in chromosome 15-related disorders[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein-associated protein N (SNRPN).